News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Paul C. Nagle

Articles by Paul C. Nagle

Defining and Characterizing the Late-stage Biopharmaceutical Pipeline

ByPaul C. Nagle,Timothy F. Lugo,Christopher A. Nicita

October 1st 2003

Latest Updated Articles

Defining and Characterizing the Late-stage Biopharmaceutical Pipeline
Published: October 1st 2003 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

How Do GLP-1 Agonists Fit Into Stroke Care?

Exploring Identity, Appearance Experiences Among Patients With Alopecia

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text